An Assessment of the Feasibility and Acceptability of a Friendship-Based Social Network Recruitment Strategy to Screen At-Risk African American and Hispanic/Latina Young Women for HIV Infection by Boyer, Cherrie B. et al.
An Assessment of the Feasibility and Acceptability of a
Friendship-Based Social Network Recruitment Strategy to
Screen At-Risk African American and Hispanic/Latina Young
Women for HIV Infection
Dr. Cherrie B. Boyer, PhD, Dr. Lisa Hightow-Weidman, MD, MPH, Dr. James Bethel, PhD,
Dr. Su X. Li, MD, Dr. Lisa Henry-Reid, MD, Dr. Donna Futterman, MD, MSN, ARNP, PNP-BC,
Mss. Donna Maturo, MSN, Dr. Diane M. Straub, MD, Ms. Kourtney Howell, BA, Mss. Shirleta
Reid, Ms. Jaime Lowe, BS, Dr. Bill G. Kapogiannis, MD, and Dr. Jonathan M. Ellen, MD
Division of Adolescent and Young Adult Medicine, Department of Pediatrics, University of
California, San Francisco (Dr Boyer); Division of Infectious Diseases, Department of Medicine,
University of North Carolina at Chapel Hill (Dr Hightow-Weidman); Westat, Rockville, Maryland
(Drs Bethel and Li); Division of Adolescent and Young Adult Medicine, Department of Pediatrics,
Stroger Hospital of Cook County, Chicago, Illinois (Dr Henry-Reid and Ms Lowe); Division of
Adolescent Medicine, Department of Pediatrics, Montefiore Medical Center, Bronx, New York (Dr
Futterman and Ms Howell); Division of Adolescent Medicine, University of Miami School of
Medicine, Miami (Mss Maturo and Reid), and Division of General Pediatrics and Adolescent
Medicine, University of South Florida, Tampa (Dr Straub), Florida; and Pediatric and Adolescent
Medicine Branch, Eunice Kennedy Shriver National Institute of Child Health and Human
Development, National Institutes of Health, Bethesda (Dr Kapogiannis), and Department of
Pediatrics, Johns Hopkins University School of Medicine, Baltimore (Dr Ellen), Maryland
Abstract
Objectives—To examine the feasibility and acceptability of a friendship-based network
recruitment strategy for identifying undiagnosed human immunodeficiency virus (HIV) infection
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within young women’s same-sex friendship networks and to determine factors that facilitated and
hindered index recruiters (IRs) in recruiting female friendship network members (FNMs) as well
as factors that facilitated and hindered FNMs in undergoing HIV screening.
Design—A cross-sectional study design that incorporated dual incentives for IRs and their
female FNMs.
Setting—The IRs were recruited through 3 Adolescent Trials Network for HIV/AIDS
Interventions sites within their Adolescent Medicine Trials Units. Data were collected from
January 1, 2009, through June 30, 2010.
Participants—The IRs self-identifying as HIV positive, negative, or status unknown were
enrolled to recruit FNMs to undergo HIV screening.
Main Outcome Measures—Self-reports of HIV risk and facilitators and barriers to network
recruitment and HIV screening were assessed using an audio-computer-assisted self-interview.
Participants were identified as HIV negative or positive on the basis of an OraQuick HIV test with
confirmatory enzyme-linked immunosorbent assay and/or Western blot tests.
Results—Nearly all (156 [98.1%]) eligible IRs agreed to participate and most (78.4%) recruited
1 or more FNMs. Of the 381 FNMs, most (342 [89.8%]) agreed to HIV screening. Although a
high acceptance of HIV screening was achieved, the HIV prevalence was low (0.26%).
Conclusion—Our findings provide compelling evidence to suggest that use of a female
friendship network approach is a feasible and acceptable means for engaging at-risk young women
in HIV screening, as shown by their high rates of agreement to undergo HIV screening.
Despite 2 decades of prevention efforts, adolescent (aged 13–19 years) and young adult
(aged 20–24 years) women are at increased risk for human immunodeficiency virus (HIV)
infection.1,2 African American and Hispanic/Latina young women have disproportionately
high rates of HIV infection. In 2009, African American young women comprised 14% of the
US female population but had 66% of the HIV infections diagnosed among females, and
Hispanic/Latina young women represented 11% of the female population but had 14% of the
HIV infections diagnosed among females.2 These data underscore the critical need for
reaching African American and Hispanic/Latina young women who are in need of primary
HIV prevention interventions, including HIV counseling and testing.
The Centers for Disease Control and Prevention recommends that every person in the United
States from 13 to 64 years old get tested for HIV.3 Despite this, nationally, among high
school students, 12% of Hispanic/Latinos and 21% of African Americans have been tested
for HIV infection.4 It is estimated that 50% of all HIV-infected adolescents are unaware of
their HIV status.5,6 Identifying undiagnosed HIV infection provides opportunities for
referrals to risk-reduction counseling, medical care, and psychosocial services as early as
possible. Consequently, it is important to establish effective strategies for identifying
undiagnosed HIV infection in African American and Hispanic/Latina young women because
they are at increased risk for HIV. To increase HIV testing and timely linkage to care, it is
necessary to understand factors that prohibit young women from seeking HIV testing7 and
factors that will make HIV testing a desirable and attainable aspect of HIV prevention.8
A social network approach has been effective in identifying HIV infections; however, this
approach has focused largely on adults, including heterosexual men and women, men with
male-to-male sexual contact, and intravenous drug users.9,10 The extent to which a social
network approach will be an effective means to screen for HIV infection in heterosexual
young women is unknown. Moreover, because there are few definitive risk factors for HIV
infection among nonintravenous drug using heterosexual young women beside
neighborhood of residence and race/ethnicity,2,11 it is likely that the social networks of HIV-
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uninfected young women residing in communities with high HIV prevalence include HIV-
infected young women,12 suggesting the need for a broader approach to social network
recruitment that would include individuals who may be HIV negative or whose HIV status is
unknown. This broad social network recruitment approach was used in this research.
Previous research also suggests that same-sex close-friendship networks may be a feasible
and acceptable approach for recruiting African American and Hispanic/Latina adolescents in
sexually transmitted infection or HIV prevention interventions.13–16 Thus, this study
examined the feasibility and acceptability of a friendship-based network recruitment strategy
for identifying undiagnosed HIV infection within the young women’s same-sex friendship
networks. We also examined factors that facilitated and hindered index recruiters (IRs) in
recruiting female friendship network members (FNMs) as well as factors that facilitated and
hindered FNMs in undergoing HIV screening.
METHODS
STUDY PARTICIPANTS
Study eligibility for all study participants included self-identifying as biologically female
and sexual intercourse with a male partner. Eligibility for IRs included self-identifying as
African American, Hispanic/Latina ethnicity, mixed African American and/or Hispanic/
Latina ethnicity, age 13 to 24 years, and self-disclosure as (1) HIV positive, (2) HIV
negative (a negative HIV test result <12 months before study consent), or (3) HIV status
unknown (no history of HIV testing or receipt of negative HIV test results >12 months
before study consent). Eligibility for FNMs was age at least 13 years. Although it was
anticipated that most of the FNMs would be African American or Hispanic/Latina, those
who self-identified as another race were not excluded from participation. Because a goal of
this research was to assess the feasibility of recruiting FNMs who may be at risk for HIV, it
was important that IRs did not restrict recruitment of FNMs on the basis of age, race/
ethnicity, or perceived risk. The FNMs were defined as “female friends you may hang out
with more than others, or trust more than others.”13,14,16
STUDY DESIGN AND SETTING
A cross-sectional design using dual incentives for IRs and FNMs was used. The IRs
received $40 to $50 for completing the assessments and for travel expenses and $10 to $20
for recruiting each FNM; FNMs received $40 to $50 for completing the assessments and for
travel expenses.
The IRs were recruited from the Adolescent Medicine Trials Units of 3 Adolescent Trials
Network for HIV/AIDS Interventions (ATN) sites (Stroger Hospital of Cook County,
Montefiore Medical Center, and the University of Miami School of Medicine). Young
women provided verbal consent to undergo a brief screening interview. If eligible, they
provided written, informed consent or assent. Parental permission was required by the
institutional review board at the University of Miami School of Medicine. All study
procedures were approved by each site’s institutional review board.
The IRs completed a brief audio-computer-assisted self-interview and received 6 referral
cards to distribute to their FNMs, which included the IRs’ subject identification number to
link IRs and FNMs. The IRs who self-identified as HIV negative or unknown were invited
to undergo HIV screening. The IRs were allowed up to 4 months to recruit their FNMs, after
which they completed an audio-computer-assisted self-interview on factors that facilitated or
hindered recruitment of FNMs. The FNMs also completed an audio-computer-assisted self-
interview to assess their HIV risk and factors that facilitated or hindered HIV screening.
Data were collected from January 1, 2009, through June 30, 2010.
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The audio-computer-assisted self-interview took approximately 40 minutes to complete and
included the following measures:
Sociodemographic Characteristics and HIV-Related Risk measures were derived from a
prior ATN-sponsored study.17,18 The behavioral HIV risk measures were created using
criteria established by Seage et al19 and expanded to include measures from Boyer et
al.20 The alcohol and substance use assessment included questions about alcohol,
marijuana, and other substances.
Facilitators for HIV Screening for IRs and FNMs comprised a 12-item, 4-point Likert
scale measure (“strongly disagree” to “strongly agree”) focusing on (1) concern about
personal health; (2) past behaviors; (3) high prevalence of HIV in own community; (4)
sexual partner’s HIV risk; (5) protecting future health; (6) girlfriend screening for HIV;
(7) free HIV testing; (8) confidential HIV testing; (9) HIV testing before study consent;
(10) benefits of HIV treatment, if positive; (11) painless test; and (12) friends’ support.
Barriers to HIV Screening for FNMs and IRs included a 13-item, 4-point Likert scale
measure (“strongly disagree” to “strongly agree”) focusing on concern about (1)
confidentiality, (2) parents receiving test results, and (3) friends’ judgment, no concern
about (4) past behaviors (5) current behaviors, (6) health, or (7) HIV in own
community; (8) indifference to painless testing; (9) embarrassment for HIV screening;
(10) fear of knowing HIV status; (11) indifference to benefits of HIV treatments; (12)
lack of time for screening; and (13) lack of trust in health care professionals. The
facilitators and barriers to HIV screening measures were developed from existing
literature7–10 and the authors’ clinical experience.
HIV tests identified participants as HIV negative or positive on the basis of oral rapid
testing using the OraQuick HIV test with confirmatory tests using enzyme-linked
immunosorbent assay and/or Western blot tests. Each site followed its specific
Adolescent Medicine Trials Unit standard-of-care protocol for providing counseling
before and after HIV screening. Participants who were given a diagnosis of HIV were
linked to medical care at each participating Adolescent Medicine Trials Unit.
STATISTICAL ANALYSIS
Conventional descriptive statistics were used to examine the characteristics of participants.
Frequencies and proportions for categorical variables and means (SDs), along with median
and range of data values for continuous variables, were calculated. Comparisons by IRs’
HIV status were performed separately for IRs and FNMs, in which χ2 or Fisher exact tests
were used for the categorical variables and analysis of variance for continuous variables.
Facilitator and barrier measures were dichotomized; “strongly agree” and “agree” were
combined as were the “disagree” and “strongly disagree” responses. Logistic regression
analyses identified facilitators and barriers that were associated with the probability of
recruiting at least 2 FNMs into the study relative to those who recruited none or 1. Data
analyses were performed using SAS, version 9.2 (SAS Institute, Inc).21
RESULTS
CHARACTERISTICS OF IRs
Sociodemographic Characteristics—Of the 156 young women who were screened to
serve as an IR, 153 (98.1%) were enrolled in the study. They were primarily African
American (70.6%) and Hispanic/Latina (27.5%), and the mean age was 20 years (Table 1).
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HIV-Related Sexual Risk—All IRs reported a history of sexual intercourse with a male
and 31.4% also reported sexual intercourse with a female. HIV risk was reported by a
sizable number of the IRs, including sexual initiation at 16 years or younger (32.7%) and a
history of pregnancy (56.2%) and sexually transmitted infections (50.3%) (Table 2).
Alcohol and Other Substance Use—Use of alcohol and other substances was also
prevalent among IRs; 80.4% reported drinking alcohol and 59.5% reported engaging in
sexual intercourse while under the influence of alcohol. Marijuana was the most prevalent
non-prescription substance used (57.5%). Sex in exchange for drugs or money was reported
by 11.8% (Table 3).
Comparisons Among IRs—Compared with IRs who were HIV negative or whose status
was unknown, IRs who were HIV positive were significantly more likely to report a higher
number of life-time (F2,142 = 5.65, P < .004) and casual sex partners (F2,109 = 4.43, P < .01);
a current sexual relationship lasting more than 1 year (χ2 = 7.82, P = .02); sex with someone
who they knew had HIV (χ2 = 36.64, P < .001); sex with a male who had been incarcerated
(χ2 = 10.21, P < .007); sex with a male who has dealt drugs (χ2 = 13.82, P < .002); a history
of sexually transmitted infections (χ2 = 19.55, P < .001); exchange of sex for drugs or
money (χ2 = 17.77, P < .001); undergoing a prior HIV test (χ2 = 47.15, P < .001); and a
longer time since their most recent HIV test (χ2 = 52.77, P < .001).
Recruitment of FNMs—On average, IRs discussed the study with 6 FNMs and recruited
a mean (SD) of 2 (2) FNMs (range, 0–7 FNMs). Overall, 33 IRs (21.6%) recruited no
FNMs, whereas 16 (10.5%) recruited 1. Forty-one IRs (26.8%) recruited 2 FNMs and 63
(41.2%) recruited 3 or more. No statistical differences were observed between IRs who
recruited less than 2 FNMs compared with those who recruited 2 or more (data not shown).
CHARACTERISTICS OF FNMs
Sociodemographic Characteristics—Three hundred eighty-one FNMs were recruited;
115 (30.2%) were recruited by IRs who were HIV positive, 146 (38.3%) were recruited by
IRs who were HIV negative, and 120 (31.5%) were recruited by IRs whose HIV status was
unknown. The FNMs were largely African American (68.5%) and 26.5% identified as
Hispanic/Latina. The mean age of FNMs was 21 years (Table 1).
HIV-Related Risk—Almost all FNMs (99.5%) reported sexual intercourse with a male and
20.5% reported sexual intercourse with a female. HIV risk factors were identified among
many of the FNMs, including sex with a male who was incarcerated (44.1%) or who has
dealt drugs (42.3%). The mean number of lifetime sexual partners was 15 and of casual
sexual partners was 7 (Table 2).
Alcohol and Other Substance Use—Alcohol use was reported by most of the FNMs
(74.8%), and nearly half (48.3%) reported engaging in sexual intercourse while using
alcohol. Marijuana use was also prevalent (51.2%) (Table 3).
Comparisons Among FNMs—The FNMs who were recruited by HIV-positive IRs were
significantly more likely to identify as African American (χ2 = 20.31, P = .02) and to report
a history of homelessness (χ2 = 8.47, P < .02); sex with a female (χ2 = 18.29, P < .001); and
sex with a male who has been incarcerated (χ2 = 7.22, P < .02). In contrast, FNMs who
were recruited by HIV-negative IRs were significantly more likely to identify as Hispanic/
Latina (χ2 = 12.81, P = .002) and to have a history of HIV testing (χ2 = 14.78, P < .004),
whereas FNMs who were recruited by IRs whose HIV status was unknown were
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significantly less likely to report drinking more than 1 drink of alcohol on a typical day (χ2
= 23.47, P = .01).
CURRENT HIV SCREENING
Index Recruiters—Of the 153 IRs, 92 (60.1%) underwent HIV screening; none was
diagnosed as HIV positive.
Friendship Network Members—Of the 381 FNMs enrolled in the study, 342 (89.8%)
were screened for HIV. Among those who were tested, 112 (32.7%) were recruited by IRs
who self-identified as HIV positive, 128 (37.4%) were recruited by IRs who self-identified
as HIV negative, and 102 (29.8%) were recruited by IRs who self-identified as HIV status
unknown. The FNMs who were screened for HIV were significantly more likely to be older
(χ2 = 54.85, P < .001), African American (χ2 = 20.48, P < .001), or currently out of school
(χ2 = 5.75, P < .05) and were more likely to report a higher level of education (χ2 = 20.85,
P < .002), a history of homelessness (χ2 = 8.47, P < .02), and a lower number of steady and
lifetime sexual partners (F1,374 = 5.52, P < .02). Of the FNMs who were screened for HIV,
only 1 was given a diagnosis of HIV positive. This participant was recruited by an HIV-
positive IR, reflecting 0.87% of the FNMs recruited by HIV-positive IRs, with an overall
HIV prevalence of 0.26%.
FACILITATORS AND BARRIERS TO RECRUITMENT OF FNMs
Facilitators for Recruiting FNMs by IRs—Most IRs (85%–90%) endorsed facilitator
statements to describe their experiences in discussing HIV screening with their FNMs. The
IRs who recruited 2 or more FNMs more frequently agreed with the following statements
than IRs who recruited none or 1 FNM: ease of speaking about HIV screening with
girlfriends (χ2 = 9.38, P < .03), telling girlfriends about the importance of knowing their
HIV status (χ2 = 11.98, P > .006), telling girlfriends about the high rate of HIV in their
community (χ2 = 10.96, P < .02), and telling girlfriends about their concern for them having
sex with an HIV-infected person (χ2 = 11.14, P < .007). Logistic regression analysis
indicated that of the facilitator statements, telling girlfriends about the importance of
knowing their HIV status (odds ratio [OR], 3.88; 95% CI, 1.18–12.76) and telling girlfriends
about the high rate of HIV in their community (3.80; 1.45–10.01) were the most salient
factors associated with recruitment of at least 2 FNMs.
Barriers to Recruiting FNMs by IRs—A number of statistical differences were
identified among barriers to recruitment of FNMs across the IRs’ HIV status, including
embarrassment in speaking about HIV screening (higher among young women who were
HIV positive; χ2 = 16.53, P < .009); friends’ concern that their parents may receive HIV test
results (lower for young women who were HIV positive; χ2 = 11.78, P < .03); and concern
that friends would assume the IRs to be HIV positive if they talked them into HIV screening
(higher among young women who were HIV positive; χ2 = 17.16, P < .01). Logistic
regression analysis assessing barriers associated with IRs recruiting less than 2 FNMs
included difficulty in speaking to girlfriends about HIV screening (OR, 4.17; 95% CI, 1.56–
11.10); lack of time to contact girlfriends (5.57; 1.38–22.44); girlfriends who were afraid to
know their HIV status (2.57; 1.06–6.22); and concern that girlfriends would assume the IR
was HIV positive (3.75; 1.51–9.33).
FACILITATORS AND BARRIERS TO HIV SCREENING AMONG FNMs
Facilitators for HIV Screening Among FNMs—Among facilitator measures endorsed
by FNMs, concern about health (χ2 = 19.17, P < .004) and free HIV tests (14.33, P < .03)
were significantly associated with HIV screening. The facilitator measures for HIV
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screening among FNMs were completed only by those who agreed to undertake HIV
screening (89.8%); thus, logistic regression modeling to compare responses between
screened and nonscreened FNMs was not feasible.
Barriers to HIV Screening Among FNMs—Among the FNMs, 39 (10.2%) did not
undergo HIV screening; of these, 3 (7.7%) were recruited by IRs who were HIV positive, 18
(46.2%) were recruited by IRs who were HIV negative, and 18 (46.2%) were recruited by
IRs whose HIV status was unknown. Most FNMs “strongly disagreed/disagreed” with most
barrier statements, including past behaviors putting them at risk for HIV infection (87.2%),
embarrassment about HIV screening (92.3%), not being concerned about their health
(94.5%), and not trusting health care professionals (84.61%). The only measure that was
marginally significant was fear of knowing the HIV status (χ2 = 11.99, P < .057). Given that
the HIV screening measure was completed by a small number of FNMs who did not agree to
undertake HIV screening, logistical regression modeling was not feasible.
COMMENT
Despite the Centers for Disease Control and Prevention’s recommendation that every person
in the United States from 13 to 64 years old be screened for HIV, it is estimated that 50% of
all HIV-infected adolescents are unaware of their infection status.6 In an attempt to address
this public health mandate and to build on recent research suggesting that female friendship-
based networks may be a practical strategy for engaging young women in sexually
transmitted infection and HIV prevention interventions,14–16 this study examined whether
social networks are a feasible and acceptable approach for engaging at-risk African
American and Hispanic/Latina young women in HIV screening. A number of social network
studies have been conducted to screen for HIV among at-risk adults,9,22–24 but little is
known about whether such a strategy would be a feasible and acceptable approach to engage
at-risk young women in HIV screening. The intent of our research was to fill this gap in
current literature. Our findings provide compelling evidence to suggest that use of a female
friendship network approach is a feasible and acceptable means for engaging at-risk young
women in HIV screening, as shown by their high rates of agreement to undergo HIV
screening.
As expected, many of the IRs and their FNMs reported risk factors that are associated with
HIV.4,25,26 This supports the need for early and sustained primary prevention interventions
for young women. The role of alcohol and other substance use as well as the potential effect
that the HIV risk of the sexual partner(s) may have on the HIV risk of young women are
important topics that should be addressed in HIV prevention interventions. Although
participants reported sexual intercourse with men who had a history of incarceration and
drug dealing, few reported sexual relationships with men who have male-to-male sexual
contact. An unexpected finding was the high rate of sexual relationships with other women,
suggesting a fluidity of sexual behavior among young women during adolescence and
emerging adulthood. As such, interventions that target at-risk young women should
emphasize the potential HIV risk during unprotected sexual intercourse with male and
female partners. Moreover, a sizeable number of young women engaged in sexual
intercourse with HIV-positive men. This suggests the need to educate young women about
the importance of avoiding unprotected sexual intercourse with someone who is known to be
HIV infected. In addition, educational strategies should include information regarding the
benefits of using preexposure and postexposure prophylaxis, as appropriate.
A unique aspect of this research was our examination of facilitators and barriers to HIV
screening. Our findings, particularly those related to barriers to recruiting FNMs, suggest
that future research should consider engaging IRs in educational and skills-building
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exercises that provide opportunities to rehearse what they might say to their FNMs, identify
appropriate times and places for raising issues around the importance of HIV screening, and
enhance their skills to avoid unintentional disclosure of their HIV status.
Our findings also indicated that many of the FNMS who agreed to undergo HIV screening
strongly endorsed statements related to concern about their health, receipt of free HIV
testing and confidential test results, the availability of treatment for those with positive test
results, and concern about the high rates of HIV in their community. Future efforts to
increase HIV screening in at-risk young women may increase receptivity if these factors are
addressed as part of the pre-HIV test counseling discussions. Having such discussions may
reinforce the young women’s decision to be screened and conversely may allay their fears
and address misconceptions among those who are undecided or who may otherwise forgo
HIV screening as a preventative health strategy.
Our lack of clear results on barriers to HIV screening among FNMs suggests the need for in-
depth qualitative studies to examine factors that prevent at-risk young women from seeking
HIV screening. Such studies should explore social, emotional, cultural, and developmental
factors that may contribute to young women’s refusal to be screened even in light of
knowledge about free and confidential screening.
Several limitations to this study should be noted. Because the study design was cross-
sectional, causal association among HIV screening, facilitators, and barriers should not be
inferred. Also, despite successfully engaging young women from 3 types of social networks
(HIV positive, negative, and status unknown) to undergo HIV screening, we yielded a very
low HIV prevalence in at-risk young women who reside in large inner-city areas with high
rates of HIV. This low prevalence may be due, in part, to the high rate of prior HIV testing
among our study participants, suggesting the need for future studies to better understand
appropriate time intervals for screening young women who engage in HIV-related
behaviors. The low HIV prevalence also provides support for the perception that there are no
clear-cut definitive HIV risk factors for young women even when they report sexual
relationships with known risky sexual partners. Future HIV screening studies involving
social networks would do well to first examine the sexual risk characteristics of the network
members and include members of the young women’s sexual network. Moreover, our
sample of young women did not report sexual bridging where their male partners also
engaged in sex with other male partners, nor did they report sex with intravenous drug users.
Although these factors may have contributed to the low HIV prevalence, providing posttest
counseling results to HIV-negative individuals is an excellent teaching opportunity to
actively engage them in risk prevention activities.27 For adolescents and emerging adults,
this may include engaging them in anticipatory guidance exercises and skills-based risk-
reduction counseling to prevent future exposure to HIV.
Despite the limitations of this research, it contributes to the growing body of literature on the
use of social networks to engage at-risk individuals in HIV screening. We demonstrated that
targeting small, close, female friendship networks is a feasible and acceptable means of
offering HIV screening to large groups of young women. However, research should explore
the conditions and circumstances under which young women refuse HIV screening, even in
light of free and confidential testing and when they express concerns about not wanting to
know their HIV status.
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